In addition, elevated plasma GLP-1 levels were linked to improved cognitive function, as assessed by Mini-Mental State Examination scores, while demonstrating an inverse correlation with plasma pTau181 levels, a biomarker associated with the progression of AD [53]. This evidence concerns the gene GLP1R and Alzheimer disease.